BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
1 | 528.10 | 545.00 | 10 |
10 | 528.05 | 560.00 | 300 |
1 | 525.00 | 571.00 | 100 |
7 | 524.75 | 612.90 | 100 |
1 | 523.40 | 628.50 | 100 |
0 | Total | Total | 0 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
1 | 528.10 | 545.00 | 10 |
10 | 528.05 | 560.00 | 300 |
1 | 525.00 | 571.00 | 100 |
7 | 524.75 | 612.90 | 100 |
1 | 523.40 | 628.50 | 100 |
0 | Total | Total | 0 |
Open | 525.00 |
Previous Close | 526.85 |
Volume | 22,937.00 |
Value (Lacs) | 121.30 |
VWAP | 526.79 |
Beta | |
Mkt Cap (Rs. Cr.) | 1,059 |
High | 532.75 |
Low | 522.90 |
UC Limit | 632.20 |
LC Limit | 421.50 |
52 Week High | 979.50 |
52 Week Low | 499.00 |
Face Value | 10.00 |
All Time High | 979.50 |
All Time Low | 85.05 |
20D Avg Volume | 21,237 |
20D Avg Delivery(%) | 57.75 |
Book Value Per Share | 319.16 |
Dividend Yield | 0.34 |
TTM EPS See historical trend | 43.11 (-11.85% YoY) |
TTM PE See historical trend | 12.27 (Average PE) |
P/B See historical trend | 1.66 (Average P/B) |
Sector PE | 39.28 |
*Delayed by 20 seconds.
Stock Score
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
6 out of 10 years Lincoln Pharmaceuticals has given positive returns in October.
Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
---|---|---|---|---|---|
October | 21.09% (2017) | 6.13% | -17.84% (2021) | -10.10% | -0.36% |
Lincoln Pharma Q1 Net Profit Rises 16.93% YoY to u20b927.70 Crore Aug 07 2025 01:13 PM
Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y Jun 24 2025 01:02 PM
Lincoln Pharma Consolidated December 2024 Net Sales at Rs 146.55 crore, up 0.07% Y-o-Y Mar 04 2025 01:33 PM
Lincoln Pharma Consolidated September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y Nov 28 2024 11:14 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 275585 | Price 600.39 | % Traded 1.37 |
Qty 275585 | Price 599.49 | % Traded 1.37 |
Qty 160300 | Price 606.04 | % Traded 0.81 |
Qty 160300 | Price 604.97 | % Traded 0.81 |
Qty 137847 | Price 600.74 | % Traded 0.69 |
Qty 125529 | Price 602.25 | % Traded 0.62 |
Qty 104690 | Price 598.87 | % Traded 0.52 |
Qty 92372 | Price 599.35 | % Traded 0.46 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Lincoln Pharma | 528.85 | 0.38 | 1,059.27 | 12.27 | 1.66 | 12.25 | -22.91 | 82 | 623 | 0.00 |
Sun Pharma | 1,670.90 | 0.75 | 400,904.88 | 38.65 | 5.80 | 15.13 | -11.49 | 10,980 | 52,578 | 0.03 |
Divis Labs | 6,474.50 | 5.59 | 171,877.63 | 74.53 | 12.53 | 14.63 | 8.96 | 2,191 | 9,360 | 0.00 |
Cipla | 1,561.80 | 3.22 | 126,156.85 | 23.39 | 4.45 | 16.90 | -3.53 | 5,291 | 27,547 | 0.00 |
Torrent Pharma | 3,532.80 | -0.50 | 119,566.01 | 59.73 | 15.93 | 25.17 | 2.60 | 1,911 | 11,516 | 0.40 |